ID

34560

Description

An Observational Study on Fatigue in Patients With Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab); ODM derived from: https://clinicaltrials.gov/show/NCT01667458

Link

https://clinicaltrials.gov/show/NCT01667458

Keywords

  1. 1/19/19 1/19/19 -
  2. 2/9/20 2/9/20 - Christian Arras
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 19, 2019

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Rheumatoid Arthritis NCT01667458

Eligibility Rheumatoid Arthritis NCT01667458

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, >/= 18 years of age
Description

ID.1

Data type

boolean

moderate to severe active rheumatoid arthritis, defined as das28 >/= 3.7
Description

ID.2

Data type

boolean

inadequate clinical response to current treatment with >/= 2 non-biologic dmards, 1 of them being methotrexate optimally administered for >/= 3 months, or inadequate clinical response to anti-tnf therapy
Description

ID.3

Data type

boolean

eligible for roactemra/actemra treatment in daily clinical practice
Description

ID.4

Data type

boolean

absence of evolutive tuberculosis (tb)
Description

ID.5

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
hypersensitivity to tocilizumab or any of the excipients
Description

ID.6

Data type

boolean

active, severe infections
Description

ID.7

Data type

boolean

pregnant or lactating women
Description

ID.8

Data type

boolean

participation in any other interventional study
Description

ID.9

Data type

boolean

patients with major depression
Description

ID.10

Data type

boolean

Similar models

Eligibility Rheumatoid Arthritis NCT01667458

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
adult patients, >/= 18 years of age
boolean
ID.2
Item
moderate to severe active rheumatoid arthritis, defined as das28 >/= 3.7
boolean
ID.3
Item
inadequate clinical response to current treatment with >/= 2 non-biologic dmards, 1 of them being methotrexate optimally administered for >/= 3 months, or inadequate clinical response to anti-tnf therapy
boolean
ID.4
Item
eligible for roactemra/actemra treatment in daily clinical practice
boolean
ID.5
Item
absence of evolutive tuberculosis (tb)
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
hypersensitivity to tocilizumab or any of the excipients
boolean
ID.7
Item
active, severe infections
boolean
ID.8
Item
pregnant or lactating women
boolean
ID.9
Item
participation in any other interventional study
boolean
ID.10
Item
patients with major depression
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial